ID: ALA1224418

Max Phase: Preclinical

Molecular Formula: C27H22Cl4N2O7

Molecular Weight: 628.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)[C@H](Cc1ccc(OCc2c(Cl)cccc2Cl)cc1)NC(=O)[C@@H]1OCO[C@H]1C(=O)Nc1c(Cl)cccc1Cl

Standard InChI:  InChI=1S/C27H22Cl4N2O7/c28-17-3-1-4-18(29)16(17)12-38-15-9-7-14(8-10-15)11-21(27(36)37)32-25(34)23-24(40-13-39-23)26(35)33-22-19(30)5-2-6-20(22)31/h1-10,21,23-24H,11-13H2,(H,32,34)(H,33,35)(H,36,37)/t21-,23+,24+/m0/s1

Standard InChI Key:  VBQLKAJJKQAJIM-QPTUXGOLSA-N

Associated Targets(Human)

Integrin alpha-4 295 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 628.29Molecular Weight (Monoisotopic): 626.0181AlogP: 5.37#Rotatable Bonds: 10
Polar Surface Area: 123.19Molecular Species: ACIDHBA: 6HBD: 3
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.13CX Basic pKa: CX LogP: 5.93CX LogD: 2.48
Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.28Np Likeness Score: -0.53

References

1. Rehman A, Soni A, Naik K, Nair S, Palle VP, Dastidar S, Ray A, Alam MS, Salman M, Cliffe IA, Sattigeri V..  (2010)  Synthesis and biological activity of N-substituted aminocarbonyl-1,3-dioxolanes as VLA-4 antagonists.,  20  (18): [PMID:20705461] [10.1016/j.bmcl.2010.07.069]

Source